These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 14734735)

  • 21. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
    Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S
    J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential roles for extracellularly regulated kinase-mitogen-activated protein kinase in B cell antigen receptor-induced apoptosis and CD40-mediated rescue of WEHI-231 immature B cells.
    Gauld SB; Blair D; Moss CA; Reid SD; Harnett MM
    J Immunol; 2002 Apr; 168(8):3855-64. PubMed ID: 11937539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
    J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas.
    Graves JD; Draves KE; Craxton A; Krebs EG; Clark EA
    J Immunol; 1998 Jul; 161(1):168-74. PubMed ID: 9647221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
    PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H2O2 inhibits BCR-dependent immediate early induction of EBV genes in Burkitt's lymphoma cells.
    Osipova-Goldberg HI; Turchanowa LV; Adler B; Pfeilschifter JM
    Free Radic Biol Med; 2009 Oct; 47(8):1120-9. PubMed ID: 19540913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification.
    Zauner L; Melroe GT; Sigrist JA; Rechsteiner MP; Dorner M; Arnold M; Berger C; Bernasconi M; Schaefer BW; Speck RF; Nadal D
    Oncogene; 2010 Aug; 29(32):4588-98. PubMed ID: 20514021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin.
    Goldfeld AE; Liu P; Liu S; Flemington EK; Strominger JL; Speck SH
    Virology; 1995 May; 209(1):225-9. PubMed ID: 7538254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes.
    Craxton A; Shu G; Graves JD; Saklatvala J; Krebs EG; Clark EA
    J Immunol; 1998 Oct; 161(7):3225-36. PubMed ID: 9759836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
    Purkerson JM; Parker DC
    J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells.
    Jordi M; Marty J; Mordasini V; Lünemann A; McComb S; Bernasconi M; Nadal D
    PLoS One; 2017; 12(10):e0186614. PubMed ID: 29088270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.
    Nagata Y; Inoue H; Yamada K; Higashiyama H; Mishima K; Kizu Y; Takeda I; Mizuno F; Hayashi Y; Saito I
    Immunology; 2004 Feb; 111(2):223-9. PubMed ID: 15027908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.
    Shimizu N; Takada K
    J Virol; 1993 Jun; 67(6):3240-5. PubMed ID: 8388498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylinositol-3-kinase activity is required for the anti-ig-mediated growth inhibition of a human B-lymphoma cell line.
    Beckwith M; Fenton RG; Katona IM; Longo DL
    Blood; 1996 Jan; 87(1):202-10. PubMed ID: 8547643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cell receptor-mediated Syk-independent activation of phosphatidylinositol 3-kinase, Ras, and mitogen-activated protein kinase pathways.
    Yokozeki T; Adler K; Lankar D; Bonnerot C
    J Immunol; 2003 Aug; 171(3):1328-35. PubMed ID: 12874222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
    Daibata M; Humphreys RE; Takada K; Sairenji T
    J Immunol; 1990 Jun; 144(12):4788-93. PubMed ID: 2161880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.